Literature DB >> 9546436

Cloning and characterization of human and mouse telomerase RNA gene promoter sequences.

J Q Zhao1, S F Hoare, R McFarlane, S Muir, E K Parkinson, D M Black, W N Keith.   

Abstract

Variation in telomerase activity is correlated with cellular senescence and tumour progression. However, although the enzymatic activity of telomerase has been well studied, very little is known about how expression of telomerase genes is regulated in mammalian cells. We have therefore cloned the promoter regions of the human (hTR), and mouse, (terc), telomerase RNA genes in order to identify the regulatory elements controlling telomerase RNA gene transcription. 1.76 kb encompassing the hTR gene promoter region was sequenced, as was 4 kb encompassing the terc promoter. No significant sequence similarity could be detected in comparisons between human and mouse 5'-regions, flanking the transcribed sequences. However, both the human and mouse telomerase RNA genes are within CpG islands and may therefore be under the regulation of DNA methylation. Transient expression of hTR-reporter gene constructs in HeLa and GM847 cells identified the elements responsible for promoter activity are contained in a 231 bp region upstream of the transcriptional start site. Transient expression of terc-reporter gene constructs in Swiss3T3 and A9 cells identified the elements responsible for promoter activity are contained in a 73 bp region upstream of the transcriptional start site. These studies have implications for novel transcription targeted cancer therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546436     DOI: 10.1038/sj.onc.1201892

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.

Authors:  Simona Nanni; Michela Narducci; Linda Della Pietra; Fabiola Moretti; Annalisa Grasselli; Piero De Carli; Ada Sacchi; Alfredo Pontecorvi; Antonella Farsetti
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Authors:  Rosalind M Glasspool; Sharon Burns; Stacey F Hoare; Catharina Svensson; W Nicol Keith
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

4.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

5.  Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.

Authors:  G Strathdee; K Appleton; M Illand; D W Millan; J Sargent; J Paul; R Brown
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Structural features of mouse telomerase RNA are responsible for the lower activity of mouse telomerase versus human telomerase.

Authors:  Scott J Garforth; Yan Yun Wu; Vinayaka R Prasad
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

7.  Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.

Authors:  X Yi; V M Tesmer; I Savre-Train; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.

Authors:  J Q Zhao; R M Glasspool; S F Hoare; A Bilsland; I Szatmari; W N Keith
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

9.  Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.

Authors:  Atsuo Nakamura; Takeshi Suda; Terasu Honma; Toru Takahashi; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yusaku Mita; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  The scaRNA2 is produced by an independent transcription unit and its processing is directed by the encoding region.

Authors:  Marie-Aline Gérard; Evelyne Myslinski; Natassia Chylak; Stéphanie Baudrey; Alain Krol; Philippe Carbon
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.